Amalgamated Bank lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 0.8% in the first quarter, according to the company in its most recent filing with the SEC. The fund owned 186,742 shares of the healthcare conglomerate's stock after buying an additional 1,446 shares during the quarter. UnitedHealth Group comprises about 0.8% of Amalgamated Bank's portfolio, making the stock its 17th largest holding. Amalgamated Bank's holdings in UnitedHealth Group were worth $97,806,000 as of its most recent filing with the SEC.
A number of other institutional investors also recently made changes to their positions in the company. NewSquare Capital LLC acquired a new stake in UnitedHealth Group during the fourth quarter worth about $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group in the fourth quarter valued at approximately $26,000. Hurley Capital LLC acquired a new position in UnitedHealth Group during the fourth quarter valued at approximately $28,000. Aster Capital Management DIFC Ltd bought a new position in shares of UnitedHealth Group in the 4th quarter valued at $30,000. Finally, Promus Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth $32,000. Institutional investors own 87.86% of the company's stock.
Insiders Place Their Bets
In related news, Director Kristen Gil purchased 3,700 shares of the firm's stock in a transaction that occurred on Thursday, May 15th. The stock was acquired at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the acquisition, the director now owns 3,818 shares of the company's stock, valued at $1,035,327.06. This represents a 3,135.59% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Stephen J. Hemsley bought 86,700 shares of the stock in a transaction dated Friday, May 16th. The stock was purchased at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the acquisition, the chief executive officer now owns 679,493 shares of the company's stock, valued at $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders have acquired 109,408 shares of company stock worth $31,607,768. Insiders own 0.28% of the company's stock.
UnitedHealth Group Trading Up 2.1%
Shares of UNH stock opened at $308.85 on Monday. The company has a market cap of $280.17 billion, a P/E ratio of 12.93, a PEG ratio of 1.46 and a beta of 0.45. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The stock has a 50 day simple moving average of $336.21 and a two-hundred day simple moving average of $453.53. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same period in the prior year, the company earned $6.91 earnings per share. Research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a $2.21 dividend. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 annualized dividend and a yield of 2.86%. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio (DPR) is presently 37.02%.
Analyst Upgrades and Downgrades
A number of research firms have recently commented on UNH. HSBC reissued a "reduce" rating and issued a $270.00 target price (down previously from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Deutsche Bank Aktiengesellschaft decreased their target price on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a research note on Wednesday, May 14th. Robert W. Baird downgraded UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 price objective on the stock. in a report on Wednesday, June 11th. Royal Bank Of Canada dropped their target price on UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating for the company in a research report on Friday, May 16th. Finally, Bank of America lowered shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and dropped their price objective for the company from $560.00 to $350.00 in a report on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of "Moderate Buy" and a consensus target price of $415.57.
View Our Latest Stock Analysis on UnitedHealth Group
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report